Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Urologic Oncology|January 7, 2023
Clinician interest in clinical decision support for PSA-based prostate cancer screeningJonathan Harper, Trevor Hunt, Mouneeb Choudry, et al.
The American Journal of Managed Care|November 29, 2017
The influence of provider characteristics and market forces on response to financial incentivesBrock O'Neil, Mark Tyson, Amy J Graves, et al.
JAMA Surgery|September 23, 2016
Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate CancerMark D Tyson, Amy J Graves, Brock O'Neil, et al.
Cancer Epidemiology|May 4, 2020
Factors associated with appropriate and low-value PSA testingNathaniel Oswald, Tengda Lin, Benjamin Haaland, et al.
Urologic Oncology|April 23, 2020
<sup>18</sup>F-fluciclovine PET CT detection of biochemical recurrent prostate cancer at specific PSA thresholds after definitive treatmentJoseph M Armstrong, Christopher R Martin, Christopher Dechet, et al.
Clinical Genitourinary Cancer|May 9, 2026
Cardiovascular Disease in a Population-Based Cohort of Prostate Cancer Patients With Long-Term Follow-UpSiqi Hu, Chun-Pin Chang, David Gill, et al.
Medical Care|November 6, 2019
Provider Practice Competition and Adoption of Medicare's Oncology Care ModelAli Jalali, Christopher Martin, Richard E Nelson, et al.
Cancer Medicine|April 15, 2025
Rural-Urban Disparities in Cancer Care-Analyzing Routinely Collected Patient-Reported Outcomes. A Cross-Sectional StudyDominik J Ose, Bayarmaa Mark, Krista Ocier, et al.
Pageof 6